Surprisingly, S100A9-deficient mice show slight decreases in the response of neutrophils to stimulation with chemoattractant (120) and slight aggravation of psoriasis symptoms compared with control mice (121), indicating functional differences between S100A8 and S100A9. Here, S100A9 is linked to psoriasis.